Multiple-dose Trial to Determine the Clinical Bioequivalence Between Tavapadon Tablets in Participants With Parkinson's Disease
Clinical trial NCT05610189 · COMPLETED
Trial details
- NCT number
- NCT05610189
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2023-12-12
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.